Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Jul 28 - Aug 2
Identification and characterization of a novel class of c-Jun N-terminal kinase inhibitors
GSK376501A is a selective peroxisome proliferator-activated receptor gamma (PPARγ) modulator for the treatment of type 2 diabetes mellitus
Chemical Name: 5-(1-methyl-1H-pyrazol-4-yl)-N-(2-methyl-5-(3-(trifluoromethyl)benzamido)phenyl)nicotinamide
Mosapride Citrate (also known as Gasmotin
IC50 values for src
(Rac)-BRD0705 - CAS# 1597440-03-3 Size:Contact [email protected] for quotation Identification and characterization of a(Rac) BRD0705 is a less active racemate of BRD0705. BRD0705 is a potent, paralog selective and orally active GSK3 inhibitor with an IC50 of 66 nM and a Kd of 4. 8 M. BRD0705 displays increased selectivity for GSK3 (8 fold) versus GSK3 (IC50 of 515 nM). BRD0705 can be used for acute myeloid leukemia (AML). Product information CAS Number: 1597440 03 3 Molecular Weight: 321. 42 Formula: C20H23N3O Chemical Name: 4 ethyl 7,7 dimethyl 4 phenyl
US$ 470.48
US$ 270.75
US$ 12.95
US$ 36.95
US$ 242.97
US$ 1571.47
US$ 29.95